ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent

June 24, 2011

PET Better At Evaluating Response In Sarcoma

February 29, 2008

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

Clinton To Propose $1 Billion Increase And A New Minority Health Center For NIH.

January 21, 2000

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997